In preliminary research, the detection of persistent leukemia-associated genetic mutations in at least 5 percent of bone marrow cells in day 30 remission samples among adult patients with acute ...
Decades ago, patients who were diagnosed with acute myeloid leukemia, a rare cancer of the bone marrow and blood, were told there was nothing doctors could do for them. In part due to pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback